Overview
An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
Status:
Completed
Completed
Trial end date:
2010-05-01
2010-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study was to investigate the long term efficacy and safety of several doses of the Melt formulation of desmopressin in a broad population of adult patients with nocturia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ferring PharmaceuticalsTreatments:
Deamino Arginine Vasopressin
Criteria
Inclusion Criteria:- Written informed consent prior to the performance of any study-related activity.
- Was randomized into Part II of Protocol FE992026 CS29 (NCT00477490), entitled "A
Randomized, Double Blind,Placebo Controlled, Parallel Group, Multi-Center Study with a
Double Blind Extension Investigating the Efficacy and Safety of a Fast-Dissolving
("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults" and have
completed at least Visit 3E in Part II (Day 15).
Exclusion Criteria:
- Patients using loop diuretics (furosemide, torsemide, ethacrynic acid).